Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease. Qing Li
Trends Immunol. 2026 Jun 23:S1471-4906(26)00138-9. doi: 10.1016/j.it.2026.06.001. Online ahead of print. ABSTRACT Growing evidence indicates that gut microbiota-derived metabolites are key regulators of immunometabolism in inflammatory bowel disease (IBD). Intestinal epithelial cells and immune cells exhibit profound metabolic alterations in IBD. Microbial metabolites act as intermediates in host-microbe communication, reshaping mitochondrial functions and cellular metabolic … Read more